PeptideDB

ZY-444

CAS No.: 1802650-31-2

ZY-444 has potential anticancer activity, inhibits PCa cell proliferation and metastasis, and inhibits the growth of sub
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Description ZY-444 has potential anticancer activity, inhibits PCa cell proliferation and metastasis, and inhibits the growth of subcutaneous tumors.
molecular weight 444.59
Molecular formula C26H28N4OS
CAS 1802650-31-2
Storage store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Solubility DMSO: 80 mg/mL (179.94 mM), Sonication is recommended.
References 1. Lin Q, et al. Targeting Pyruvate Carboxylase by a Small Molecule Suppresses Breast Cancer Progression. Adv Sci (Weinh). 2020 Mar 12;7(9):1903483. 2. Han MT, et al. ZY-444 inhibits the growth and metastasis of prostate cancer by targeting TNFAIP3 through TNF signaling pathway. Am J Cancer Res. 2023 Apr 15;13(4):1533-1546.